Market Overview:
The global manidipine hydrochloride market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of hypertension and renal impairment, and the growing demand for manidipine hydrochloride in emerging markets. Based on type, the global manidipine hydrochloride market can be segmented into powder and capsule. The powder segment is expected to account for a larger share of the market than the capsule segment during the forecast period. This can be attributed to its lower cost as compared with capsules and its ease of use. Based on application, the global manidipine hydrochloride market can be divided into hypertension, renal impairment, and others (including angina pectoris). Hypertension is estimated to account for a major share of this market during the forecast period owing to rising incidence rates globally.
Product Definition:
A calcium channel blocker that is used to treat hypertension. It relaxes the muscles of the heart and blood vessels, which lowers blood pressure.
Powder:
Powder is a form of solid dosage for oral administration. It consists of microcrystalline cellulose, crospovidone, and stearic acid in an amount sufficient to produce an effective dose.
Capsule:
Capsule is a gelatin-based shell, which contains drug substance and a carrier for delivering the drug to target site. It is generally used in oral solid dosage forms. Capsules are available in different sizes, shapes and can be manufactured using various materials such as glass, plastic or aluminum foil.
Application Insights:
The others segment dominated the global market in 2017, accounting for over 60% share of the total revenue. The segment includes diabetic retinopathy, macular degeneration and glaucoma. Manidipine is used to treat these conditions due to its ability to reduce ocular pressure which results in reduction of damage caused by these diseases.
High blood pressure is one of the major problems facing many countries worldwide including U.S., China and India owing to which many pharmaceutical companies are developing new drugs with different mechanism of action for treating high blood pressure such as ACE inhibitors, angiotensin II receptor antagonists etc. However, due to lack of large scale clinical trials data supporting its use in hypertension application manidipine hydrochloride can be a costly drug leading from private or public health insurance plans thus making it inaccessible for most patients suffering from hypertension or other related conditions requiring long-term treatment (elderly).
Regional Analysis:
Asia Pacific dominated the global market in 2017. The presence of key players and high medication volumes have fueled the growth of this regional market. China, India, Japan, Australia and South Korea are some of the major markets that contributed to APAC’s dominance in 2017. In addition, increasing healthcare spending along with rising awareness about new products is expected to fuel growth over the forecast period.
The European region accounted for a share of more than 20% in terms of revenue in 2017 owing to its well-established pharmaceutical sector coupled with favorable government policies regarding R&D investments by companies operating within it. Moreover, growing demand for antiplatelet & anticoagulant drugs is anticipated to boost product demand over the forecast period as these medicines help prevent heart attacks & strokes among others which are major causes of mortality rate increases globally (as per WHO).
Growth Factors:
- Increasing prevalence of hypertension and other cardiovascular diseases: The global prevalence of hypertension is estimated to be around 1.13 billion in 2015 and is projected to reach 1.56 billion by 2025, according to a study published in the journal “The Lancet” in 2016. This will create a large pool of patients who will require treatment, thereby driving the demand for manidipine hydrochloride.
- Growing awareness about the benefits of early diagnosis and treatment: There is an increasing awareness among people about the importance of early diagnosis and treatment for various diseases, including hypertension. This is likely to drive demand for manidipine hydrochloride in the coming years.
- Rising geriatric population: The global geriatric population (aged 65 years or above) is expected to reach nearly 2 billion by 2050, according to a study published by United Nations Population Fund (UNFPA) in 2017 . This growing population segment will require increased access to healthcare services, including drugs such as manidipine hydrochloride for treating hypertension and other cardiovascular diseases..
Scope Of The Report
Report Attributes
Report Details
Report Title
Manidipine Hydrochloride Market Research Report
By Type
Powder, Capsule
By Application
Hypertension, Renal Impairment, Others
By Companies
JEIL PHARMACEUTICAL, Manus Aktteva Biopharma LLP, Toronto Research Chemicals, Watanabe Chemical Co., Ltd, Xi'an Sonwu Biotech Co., Ltd., Hefei Joye Import & Export Co., Ltd, JEIL PHARMACEUTICAL
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
171
Number of Tables & Figures
120
Customization Available
Yes, the report can be customized as per your need.
Global Manidipine Hydrochloride Market Report Segments:
The global Manidipine Hydrochloride market is segmented on the basis of:
Types
Powder, Capsule
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hypertension, Renal Impairment, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- JEIL PHARMACEUTICAL
- Manus Aktteva Biopharma LLP
- Toronto Research Chemicals
- Watanabe Chemical Co., Ltd
- Xi'an Sonwu Biotech Co., Ltd.
- Hefei Joye Import & Export Co., Ltd
- JEIL PHARMACEUTICAL
Highlights of The Manidipine Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Capsule
- By Application:
- Hypertension
- Renal Impairment
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Manidipine Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Manidipine hydrochloride is a calcium channel blocker. It works by preventing the flow of calcium through the channels in your heart, which can reduce your risk of heart attack and other cardiovascular problems.
Some of the major players in the manidipine hydrochloride market are JEIL PHARMACEUTICAL, Manus Aktteva Biopharma LLP, Toronto Research Chemicals, Watanabe Chemical Co., Ltd, Xi'an Sonwu Biotech Co., Ltd., Hefei Joye Import & Export Co., Ltd, JEIL PHARMACEUTICAL.
The manidipine hydrochloride market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Manidipine Hydrochloride Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Manidipine Hydrochloride Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Manidipine Hydrochloride Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Manidipine Hydrochloride Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Manidipine Hydrochloride Market Size & Forecast, 2018-2028
4.5.1 Manidipine Hydrochloride Market Size and Y-o-Y Growth
4.5.2 Manidipine Hydrochloride Market Absolute $ Opportunity
Chapter 5 Global Manidipine Hydrochloride Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Manidipine Hydrochloride Market Size Forecast by Type
5.2.1 Powder
5.2.2 Capsule
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Manidipine Hydrochloride Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Manidipine Hydrochloride Market Size Forecast by Applications
6.2.1 Hypertension
6.2.2 Renal Impairment
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Manidipine Hydrochloride Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Manidipine Hydrochloride Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Manidipine Hydrochloride Analysis and Forecast
9.1 Introduction
9.2 North America Manidipine Hydrochloride Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Manidipine Hydrochloride Market Size Forecast by Type
9.6.1 Powder
9.6.2 Capsule
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Manidipine Hydrochloride Market Size Forecast by Applications
9.10.1 Hypertension
9.10.2 Renal Impairment
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Manidipine Hydrochloride Analysis and Forecast
10.1 Introduction
10.2 Europe Manidipine Hydrochloride Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Manidipine Hydrochloride Market Size Forecast by Type
10.6.1 Powder
10.6.2 Capsule
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Manidipine Hydrochloride Market Size Forecast by Applications
10.10.1 Hypertension
10.10.2 Renal Impairment
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Manidipine Hydrochloride Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Manidipine Hydrochloride Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Manidipine Hydrochloride Market Size Forecast by Type
11.6.1 Powder
11.6.2 Capsule
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Manidipine Hydrochloride Market Size Forecast by Applications
11.10.1 Hypertension
11.10.2 Renal Impairment
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Manidipine Hydrochloride Analysis and Forecast
12.1 Introduction
12.2 Latin America Manidipine Hydrochloride Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Manidipine Hydrochloride Market Size Forecast by Type
12.6.1 Powder
12.6.2 Capsule
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Manidipine Hydrochloride Market Size Forecast by Applications
12.10.1 Hypertension
12.10.2 Renal Impairment
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Manidipine Hydrochloride Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Manidipine Hydrochloride Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Manidipine Hydrochloride Market Size Forecast by Type
13.6.1 Powder
13.6.2 Capsule
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Manidipine Hydrochloride Market Size Forecast by Applications
13.10.1 Hypertension
13.10.2 Renal Impairment
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Manidipine Hydrochloride Market: Competitive Dashboard
14.2 Global Manidipine Hydrochloride Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 JEIL PHARMACEUTICAL
14.3.2 Manus Aktteva Biopharma LLP
14.3.3 Toronto Research Chemicals
14.3.4 Watanabe Chemical Co., Ltd
14.3.5 Xi'an Sonwu Biotech Co., Ltd.
14.3.6 Hefei Joye Import & Export Co., Ltd
14.3.7 JEIL PHARMACEUTICAL
